Starting from their ability to modulate cellular signaling pathways and transcription factors important in IBD progression such as proinflammatory interleukins and eicosanoids or TNF-alpha production, polyphenols also have been assessed as candidate treatments in IBD animal models. Here, TNF is linked to inflammatory bowel disease.